Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29 Business Wire - Mon Mar 30, 6:15AM CDT

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April...

BLCO.TO : 21.90 (+2.91%)
BLCO : 15.90 (+4.19%)
BLCO
3 Reasons BLCO is Risky and 1 Stock to Buy Instead StockStory - Wed Mar 25, 11:02PM CDT

3 Reasons BLCO is Risky and 1 Stock to Buy Instead

BLCO : 15.90 (+4.19%)
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma Business Wire - Mon Mar 23, 6:00AM CDT

Both primary effectiveness endpoints were met, demonstrating statistically significant and clinically meaningful intraocular pressure reduction. ELIOS is an implant-free procedure that...

BLCO.TO : 21.90 (+2.91%)
BLCO : 15.90 (+4.19%)
Bausch + Lomb Launches R&D “Teach-in” Webinar Series Business Wire - Mon Mar 9, 6:15AM CDT

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the first event in an R&D “Teach-in” webinar series...

BLCO.TO : 21.90 (+2.91%)
BLCO : 15.90 (+4.19%)
IART
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know StockStory - Fri Mar 6, 1:00PM CST

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

UHS : 178.65 (-1.89%)
IART : 9.31 (+2.08%)
GEHC : 70.92 (+3.13%)
BLCO : 15.90 (+4.19%)
ICUI : 128.25 (+2.29%)
FRSH
2 Profitable Stocks Worth Investigating and 1 We Ignore StockStory - Wed Mar 4, 10:43PM CST

2 Profitable Stocks Worth Investigating and 1 We Ignore

FRSH : 8.04 (+0.31%)
AZZ : 125.16 (+3.36%)
BLCO : 15.90 (+4.19%)
BLCO
5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call StockStory - Tue Feb 24, 11:36PM CST

5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

BLCO : 15.90 (+4.19%)
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY® Business Wire - Tue Feb 24, 6:00AM CST

Global review highlights increasing prevalence of noninfectious ocular redness due to digital eye strain, dry eye disease, allergies and environmental exposures LUMIFY redness reliever...

BLCO.TO : 21.90 (+2.91%)
BLCO : 15.90 (+4.19%)
VNT
3 Small-Cap Stocks We Steer Clear Of StockStory - Sun Feb 22, 10:36PM CST

3 Small-Cap Stocks We Steer Clear Of

BLCO : 15.90 (+4.19%)
NVAX : 8.12 (+0.37%)
VNT : 35.31 (+3.22%)
BLCO
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus StockStory - Wed Feb 18, 11:31PM CST

BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

BLCO : 15.90 (+4.19%)

Barchart Exclusives

Bank of America Is Betting That Billionaires Could Help Take TripAdvisor Stock 50% Higher Barchart - 7 minutes ago
Activist investor Starboard Value’s growing influence could unlock hidden value inside TripAdvisor and drive a sharp re-rating in the stock Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.